Education
About Us
Working with TipRanks
Follow Us
Blaine Davis Insider Profile
4 Followers
Blaine Davis, CFO at Protara Therapeutics, holds 121.22K shares in Cartesian Therapeutics (Ticker: RNAC), holds 20.66K shares in Protara Therapeutics (Ticker: TARA). Most recently, Blaine Davis Sold ― shares of Cartesian Therapeutics on Jan 08, 2026 for an estimated value of $72.12K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-0.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Blaine Davis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 07, 2025 - Jan 07, 2026
Return:+54.70%
The most profitable trade made by Blaine Davis
Blaine Davis's Trading History
Protara Therapeutics
Jul 19, 2022
CFO
Uninformative Sell
15.90K
$103.52K
Cartesian Therapeutics
Jan 08, 2026
CFO
Informative Sell
72.12K
$899.45K
List of latest transactions for each holding click on a transaction to see Blaine Davis's performance on stock
You May Also Like
Blaine Davis insider profile FAQ
What is the percentage of profitable transactions made by Blaine Davis?
The percentage of profitable transactions made by Blaine Davis is 33%.
What is the average return per transaction made by Blaine Davis?
The average return per transaction made by Blaine Davis is -0.70%.
What stocks does Blaine Davis hold?
Blaine Davis holds: TARA, RNAC stocks.
What was Blaine Davis’s latest transaction?
Blaine Davis latest transaction was an Informative Sell of $72.12K.
What was Blaine Davis's most profitable transaction?
Blaine Davis’s most profitable transaction was an Informative Sell of RNAC stock on January 7, 2025. The return on the trade was 54.70%.
What is Blaine Davis's role in Protara Therapeutics?
Blaine Davis's role in Protara Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.